Asep Medical Holdings Inc (SEPSF)
USD 0.39
(0.0%)
USD 0.39
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -113.74 Thousand CAD | 26.81% |
| 2022 | -155.4 Thousand CAD | 12.29% |
| 2021 | -177.17 Thousand CAD | -569.83% |
| 2020 | -26.45 Thousand CAD | -529.4% |
| 2019 | 6160.00 CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -253.26 Thousand CAD | -362.39% |
| 2024 Q2 | -252.76 Thousand CAD | 113.67% |
| 2023 FY | -113.74 Thousand CAD | 26.81% |
| 2023 Q3 | -34.6 Thousand CAD | -97.3% |
| 2023 Q2 | -17.54 Thousand CAD | -157.31% |
| 2023 Q1 | -6817.00 CAD | 97.87% |
| 2023 Q4 | -54.77 Thousand CAD | -58.26% |
| 2022 Q2 | -51.03 Thousand CAD | -240.12% |
| 2022 Q1 | -15 Thousand CAD | 91.53% |
| 2022 FY | -155.4 Thousand CAD | 12.29% |
| 2022 Q4 | -320.5 Thousand CAD | -4912.59% |
| 2022 Q3 | -6394.00 CAD | 87.47% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 FY | -177.17 Thousand CAD | -569.83% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q4 | -177.17 Thousand CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2020 FY | -26.45 Thousand CAD | -529.4% |
| 2019 FY | 6160.00 CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Qrons Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.095% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 64.401% |
| Adynxx, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 180.954% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 101.183% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.737% |
| CSL Limited | 7.56 Billion USD | 100.002% |
| Arch Therapeutics, Inc. | -2439.00 USD | -4563.387% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.972% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.559% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 164.42% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 8.459% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -135.687% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.758% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 3766.667% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 101.161% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 273.046% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -233.06% |
| Mesoblast Limited | -35.16 Million USD | 99.677% |
| Marizyme, Inc. | 457.7 Thousand USD | 124.85% |
| Genus plc | 178.7 Million USD | 100.064% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.052% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 282.785% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 127.73% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -934.0% |
| ContraFect Corporation | -154 Thousand USD | 26.143% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -127.48% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 248.174% |
| IMV Inc. | -962.29 Thousand USD | 88.18% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 70.648% |
| MultiCell Technologies, Inc. | 49.32 USD | 230716.383% |
| ONE Bio Corp. | 20.12 Million USD | 100.565% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.282% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 332.597% |
| Q BioMed Inc. | -8988.00 USD | -1165.465% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.403% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -637.422% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.256% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 90.037% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 262.486% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -2196.85% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -16.638% |
| GB Sciences, Inc. | -624.00 USD | -18127.564% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -32.213% |
| HST Global, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -54582.692% |
| Enzolytics Inc. | 30.7 Thousand USD | 470.392% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 123.576% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.01% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 77.894% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 118.423% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.028% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -1184.327% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -35.649% |
| Kadimastem Ltd | -630.13 Thousand USD | 81.95% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 111.512% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -861.048% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 164.42% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 108.381% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -292.207% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 125.273% |
| SYBLEU INC | 11.69 Thousand USD | 1072.469% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 102.468% |
| Bioxytran, Inc. | -8285.00 USD | -1272.842% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 69.507% |
| Neutra Corp. | 14.33 Thousand USD | 893.443% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -38.707% |
| PureTech Health plc | -1.6 Million USD | 92.905% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 88.64% |
| IXICO plc | 3.27 Million USD | 103.478% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 83.611% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 93.649% |
| CSL Limited | 7.7 Billion USD | 100.001% |
| Cellectis S.A. | 18 Thousand USD | 731.889% |